Anne Börjesson‐Hanson

3.5k total citations
40 papers, 1.2k citations indexed

About

Anne Börjesson‐Hanson is a scholar working on Psychiatry and Mental health, Physiology and Neurology. According to data from OpenAlex, Anne Börjesson‐Hanson has authored 40 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Psychiatry and Mental health, 16 papers in Physiology and 7 papers in Neurology. Recurrent topics in Anne Börjesson‐Hanson's work include Dementia and Cognitive Impairment Research (21 papers), Alzheimer's disease research and treatments (16 papers) and Neurological Disease Mechanisms and Treatments (4 papers). Anne Börjesson‐Hanson is often cited by papers focused on Dementia and Cognitive Impairment Research (21 papers), Alzheimer's disease research and treatments (16 papers) and Neurological Disease Mechanisms and Treatments (4 papers). Anne Börjesson‐Hanson collaborates with scholars based in Sweden, United Kingdom and United States. Anne Börjesson‐Hanson's co-authors include Ingmar Skoog, Svante Östling, Silke Kern, Margda Wærn, Kaj Blennow, Henrik Zetterberg, Jürgen Kern, Deborah Gustafson, Xinxin Guo and Pia Gudmundsson and has published in prestigious journals such as Nature Medicine, Brain and Neurology.

In The Last Decade

Anne Börjesson‐Hanson

39 papers receiving 1.1k citations

Peers

Anne Börjesson‐Hanson

PMH

PHYSI

NEURO

Galit Weinstein Israel

Anne‐Brita Knapskog Norway

Qiumin Qu China

Jee Wook Kim South Korea

Cuibai Wei China

Helena Chui United States

Cecilia Camarda Italy

Yong Ji China

J. Scott Andrews United States

Hyun‐Sik Yang United States

Galit Weinstein Israel

Anne Börjesson‐Hanson

355 ×0.7

PMH

563 ×1.4

PHYSI

187 ×0.9

NEURO

81 ×0.5

NEURO

211 ×1.4

Citations per year, relative to Anne Börjesson‐Hanson Anne Börjesson‐Hanson (= 1×) peers Galit Weinstein

Countries citing papers authored by Anne Börjesson‐Hanson

Since Specialization

Citations

This map shows the geographic impact of Anne Börjesson‐Hanson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne Börjesson‐Hanson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne Börjesson‐Hanson more than expected).

Fields of papers citing papers by Anne Börjesson‐Hanson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne Börjesson‐Hanson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne Börjesson‐Hanson. The network helps show where Anne Börjesson‐Hanson may publish in the future.

Co-authorship network of co-authors of Anne Börjesson‐Hanson

This figure shows the co-authorship network connecting the top 25 collaborators of Anne Börjesson‐Hanson. A scholar is included among the top collaborators of Anne Börjesson‐Hanson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne Börjesson‐Hanson. Anne Börjesson‐Hanson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chen, Kewei, Eric M. Reiman, Kaj Blennow, et al.. (2024). p75 neurotrophin receptor modulation in mild to moderate Alzheimer disease: a randomized, placebo-controlled phase 2a trial. Nature Medicine. 30(6). 1761–1770. 22 indexed citations

Abdullah, Laila, Fiona Crawford, Magda Tsolaki, et al.. (2020). The Influence of Baseline Alzheimer's Disease Severity on Cognitive Decline and CSF Biomarkers in the NILVAD Trial. Frontiers in Neurology. 11. 149–149. 20 indexed citations

Timmers, Maarten, Ina Tesseur, Jennifer Bogert, et al.. (2019). Relevance of the interplay between amyloid and tau for cognitive impairment in early Alzheimer's disease. Neurobiology of Aging. 79. 131–141. 28 indexed citations

Timmers, Maarten, Johannes Streffer, Alberto Russu, et al.. (2018). Pharmacodynamics of atabecestat (JNJ-54861911), an oral BACE1 inhibitor in patients with early Alzheimer’s disease: randomized, double-blind, placebo-controlled study. Alzheimer s Research & Therapy. 10(1). 85–85. 73 indexed citations

Skoog, Ingmar, Silke Kern, Henrik Zetterberg, et al.. (2018). Low Cerebrospinal Fluid Aβ₄₂ and Aβ₄₀ are Related to White Matter Lesions in Cognitively Normal Elderly. Journal of Alzheimer s Disease. 62(4). 1877–1886. 14 indexed citations

Skoog, Johan, Kristoffer Bäckman, Hanna Falk, et al.. (2017). A Longitudinal Study of the Mini‐Mental State Examination in Late Nonagenarians and Its Relationship with Dementia, Mortality, and Education. Journal of the American Geriatrics Society. 65(6). 1296–1300. 16 indexed citations

Karlsson, Björn, Robert Sigström, Svante Östling, et al.. (2016). DSM-IV and DSM-5 Prevalence of Social Anxiety Disorder in a Population Sample of Older People. American Journal of Geriatric Psychiatry. 24(12). 1237–1245. 11 indexed citations

Skoog, Ingmar, Margda Wærn, Paul R. Duberstein, et al.. (2015). A 9-Year Prospective Population-Based Study on the Association Between the APOE*E4 Allele and Late-Life Depression in Sweden. Biological Psychiatry. 78(10). 730–736. 62 indexed citations

Kern, Silke, Ingmar Skoog, Anne Börjesson‐Hanson, et al.. (2014). Higher CSF interleukin-6 and CSF interleukin-8 in current depression in older women. Results from a population-based sample. Brain Behavior and Immunity. 41. 55–58. 76 indexed citations

10.

Fässberg, Madeleine Mellqvist, Svante Östling, Anne Börjesson‐Hanson, Ingmar Skoog, & Margda Wærn. (2013). Suicidal feelings in the twilight of life: a cross-sectional population-based study of 97-year-olds. BMJ Open. 3(2). e002260–e002260. 27 indexed citations

11.

Joas, Erik, et al.. (2013). Prevalence of cardiovascular disorders and risk factors in two 75-year-old birth cohorts examined in 1976–1977 and 2005–2006. Aging Clinical and Experimental Research. 25(4). 377–383. 24 indexed citations

12.

Craggs, Lucinda, Christian Hagel, Gregor Kuhlenbäeumer, et al.. (2013). Quantitative Vascular Pathology and Phenotyping Familial and Sporadic Cerebral Small Vessel Diseases. Brain Pathology. 23(5). 547–557. 47 indexed citations

13.

Kern, Silke, Ingmar Skoog, Svante Östling, Jürgen Kern, & Anne Börjesson‐Hanson. (2012). Does low-dose acetylsalicylic acid prevent cognitive decline in women with high cardiovascular risk? A 5-year follow-up of a non-demented population-based cohort of Swedish elderly women. BMJ Open. 2(5). e001288–e001288. 33 indexed citations

14.

Andersson, Mats, Xinxin Guo, Anne Börjesson‐Hanson, et al.. (2012). A population-based study on dementia and stroke in 97 year olds. Age and Ageing. 41(4). 529–533. 18 indexed citations

15.

Sundal, Christina, Sven Ekholm, Claes Nordborg, et al.. (2011). Update of the original HDLS kindred: divergent clinical courses. Acta Neurologica Scandinavica. 126(1). 67–75. 9 indexed citations

16.

Lesén, Eva, Anders Carlsten, Ingmar Skoog, et al.. (2011). Psychotropic drug use in relation to mental disorders and institutionalization among 95-year-olds: a population-based study. International Psychogeriatrics. 23(8). 1270–1277. 5 indexed citations

17.

Thorvaldsson, Valgeir, Stuart MacDonald, Laura Fratiglioni, et al.. (2010). Onset and Rate of Cognitive Change Before Dementia Diagnosis: Findings From Two Swedish Population-Based Longitudinal Studies. Journal of the International Neuropsychological Society. 17(1). 154–162. 33 indexed citations

18.

Börjesson‐Hanson, Anne, Margda Wærn, Svante Östling, Deborah Gustafson, & Ingmar Skoog. (2010). One-Month Prevalence of Mental Disorders in a Population Sample of 95-Year Olds. American Journal of Geriatric Psychiatry. 19(3). 284–291. 9 indexed citations

19.

Börjesson‐Hanson, Anne, Christopher M. Morris, Thalia Moss, et al.. (2007). Hereditary multi-infarct dementia of the Swedish type is a novel disorder different from NOTCH3 causing CADASIL. Brain. 130(2). 357–367. 41 indexed citations

20.

Wancata, Johannes, Anne Börjesson‐Hanson, Svante Östling, Karin Sjögren, & Ingmar Skoog. (2007). Diagnostic Criteria Influence Dementia Prevalence. American Journal of Geriatric Psychiatry. 15(12). 1034–1045. 50 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact